Ovarian Cancer Prevention Program
Final rept. 30 Sep 1998-29 Sep 2002
FOX CHASE CANCER CENTER PHILADELPHIA PA
Pagination or Media Count:
The goals of this research are to develop interdisciplinary studies of the etiology, biology and prevention of ovarian cancer. Project I, Ovarian Cancer Consortium has registered 955 participants including 464 high-risk women representing 329 families. The Core Laboratory has collected, processed and banked biospecimens from 496 subjects. Project II, Facilitating Decision Making About Prophylactic Oophorectomy we accrued 80 participants with a family history of ovarian cancer into the study. At the three-month follow up assessment, 86 of participants 6880 completed and returned their packets. Seventy-four percent of women 5980 continued their participation through the 6-month assessment, and 69 5580 completed the final questionnaire packed at the 12-month assessment time point. Project III, Phase II Chemoprevention Study of Ovarian Cancer this placebo-controlled randomized protocol using 4HPR has been written, approved by the Dept. of Defense, the National Cancer Institute Chemoprevention Branch, and the FDA.
- Medicine and Medical Research